Application of robotics to steady state enzyme kinetics: analysis of tight-binding inhibitors of dipeptidyl peptidase IV.

Anal Biochem

Department of Metabolic Research, Division of Metabolic and Cardiovascular Drug Discovery, Bristol-Myers Squibb, Hopewell, NJ 08534, USA.

Published: October 2003


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Using available commercial robotics and instrumentation, we developed a fully automated and rigorous steady state enzyme kinetic assay for dipeptidyl peptidase IV (DPP IV; E.C. 3.4.14.5). The automated assay was validated with isoleucyl thiazolidide, a potent inhibitor of DPP IV with K(is)=110nM. Signal window analysis indicated that the assay had a 98% probability of detecting an inhibitor yielding 15% inhibition, with a predicted false positive rate of 0.13%. A mechanistic inhibition version of the automated assay was validated with isoleucyl 4-cyanothiazolidide, a very potent inhibitor of DPP IV. Isoleucyl 4-cyanothiazolidide was a competitive inhibitor of purified porcine DPP IV with K(is)=1 nM. Similar K(is) values were obtained for purified rat DPP IV and for DPP IV activity in human plasma from normal and diabetic donors. The pH dependence of K(is) for isoleucyl 4-cyanothiazolidide yielded a bell-shaped profile, with pK(a)=5.0 and pK(b)=7.6. To date, over 100,000 data points have been generated in profiling targeted compound libraries and in the analysis of tight-binding inhibitors of DPP IV. The data also show that robotic analysis is capable of producing full mechanistic inhibition analysis in a timely fashion to support drug discovery.

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0003-2697(03)00434-2DOI Listing

Publication Analysis

Top Keywords

isoleucyl 4-cyanothiazolidide
12
steady state
8
state enzyme
8
analysis tight-binding
8
tight-binding inhibitors
8
dipeptidyl peptidase
8
automated assay
8
assay validated
8
validated isoleucyl
8
potent inhibitor
8

Similar Publications

Application of robotics to steady state enzyme kinetics: analysis of tight-binding inhibitors of dipeptidyl peptidase IV.

Anal Biochem

October 2003

Department of Metabolic Research, Division of Metabolic and Cardiovascular Drug Discovery, Bristol-Myers Squibb, Hopewell, NJ 08534, USA.

Using available commercial robotics and instrumentation, we developed a fully automated and rigorous steady state enzyme kinetic assay for dipeptidyl peptidase IV (DPP IV; E.C. 3.

View Article and Find Full Text PDF